Anti-TNF biosimilars in psoriasis: from scientific evidence to real-world experience

Keyphrases

• Real-world Experience 100%
• Psoriasis 100%
• Anti-tumor Necrosis Factor (anti-TNF) 100%
• Biosimilar 100%
• Rheumatoid Arthritis 25%
• Psoriasis Disease 25%
• Anti-tumor Necrosis Factor Agents 25%
• Drug Use 12%
• Biological Treatment 12%
• Adalimumab 12%
• Infliximab 12%
• Clinical Testing 12%
• Tumour Necrosis Factor Inhibitor (TNFi) 12%
• Etanercept 12%
• Clinical Trial Data 12%
• Psoriasis Treatment 12%
• Undertreated 12%
• Cost Savings 12%
• Biologic Therapy 12%
• Biologic-naïve 12%
• Cost Differentials 12%

Medicine and Dentistry

• Tumor Necrosis Factor 100%
• Psoriasis 100%
• Biosimilar 100%
• TNF Inhibitor 33%
• Clinician 22%
• Health Care Cost 22%
• Rheumatoid Arthritis 22%
• Biological Product 22%
• Clinical Trial 11%
• Adalimumab 11%
• Infliximab 11%
• Biological Therapy 11%
• Etanercept 11%